Disparities in outcomes of pancreatic cancer hospitalizations: A ten-year trend study. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not ...

If it’s unresectable, you need therapy that goes everywhere in the body and that is generally chemotherapy.” Symptoms of ...

Conventional radiotherapy, with or without chemotherapy, has been used to treat patients with advanced-stage pancreatic cancer, an approach with high rates of local recurrence. Stereotactic body ...

Toxicology and clinical protocol development of DUO-207: An ultrasmall nanomedicine co-delivering gemcitabine and paclitaxel for the treatment of metastatic pancreatic cancer. This is an ASCO Meeting ...

The San Francisco biotech confirmed that neither the PanCAN Precision Promise study in metastatic pancreatic cancer nor the LAPIS trial in patients with locally advanced, unresectable pancreatic ...

The accuracy for spinal lesions was reported to be 0.3 ± 0.1 mm. [37] Figure 1 shows a CyberKnife-based SBRT plan for pancreatic cancer.

type 1 (MEN-1), is a genetic disorder that affects the body's hormone-producing glands. MEN-1 can lead to tumors in the parathyroid, pancreas, and pituitary glands. These tumors may produce excess ...

“It offers a novel way to find pancreas cancer earlier without causing much damage to the body,” said team member Akihisa Fukuda, an associate professor of gastroenterology at Kyoto Universit ...

Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma ...